As the COVID-19 pandemic spreads worldwide and the number of affected individuals continues to grow, the race is on to find a cure for the novel coronavirus. COVID-19 is a strain from the coronavirus family that causes illness from as mild as the common cold to more severe cases such as pneumonia, severe acute respiratory syndrome, kidney failure, and to the most extreme case, death.
Artificial Intelligence is an emerging transformative technology that is poised to revolutionize the way we live. The race is on to build AI systems that successfully simulate human intelligence. Companies have begun to recognize the advantages AI can bring into their products and have started pouring investments into research & development (R&D) efforts in the field, investing in larger compute power, and acquiring talent from universities and start-up companies. Notably, the increasing adoption of AI has resulted into a predicted significant growth increase in the AI market, with market growth rate estimates reaching as high as 60% for 2017-2022 [1].
Services
Links
Sign up to receive first access to our reports, the latest patent news, and other updates —
all delivered to your inbox.
Sign up now to receive monthly patent news, analysis and free insight reports.
We don’t spam, we promise.
Disclaimer:
1. Parola Analytics and Avontis are distinct entities and operate independently. Any references to Avontis or its services do not constitute a legal partnership.
2. Parola Analytics does not provide legal services. Our services are limited to research and technical analysis. Any information provided by Parola Analytics should not be construed as legal advice.